Erythropoiesis-stimulating agents in kidney and cardiac disease

被引:1
|
作者
Fluck, Richard [1 ]
机构
[1] Derby City Gen Hosp, Dept Renal Med, Derby DE22 3NE, England
关键词
D O I
10.12968/hmed.2006.67.10.22060
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
for the last 20 years, erythropoiesis-stimulating agents have transformed the lives of renal dialysis patients, and they are now being used to correct anaemia in chronic kidney disease and after renal transplantation. In future, these drugs may be used outside the renal clinic to improve outcomes in patients with chronic heart failure.
引用
收藏
页码:533 / 537
页数:5
相关论文
共 50 条
  • [1] Biosimilar Erythropoiesis-Stimulating Agents in Chronic Kidney Disease
    Shah, Hitesh H.
    Fishbane, Steven
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2019, 26 (04) : 267 - 271
  • [2] Erythropoiesis-stimulating agents for anaemia in chronic kidney disease: are they all the same?
    Mudge, David W.
    Webster, Angela C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (12):
  • [3] Treatment with erythropoiesis-stimulating agents in chronic kidney disease patients with cancer
    Hazzan, Azzour D.
    Shah, Hitesh H.
    Hong, Susana
    Sakhiya, Vipulbhai
    Wanchoo, Rimda
    Fishbane, Steven
    KIDNEY INTERNATIONAL, 2014, 86 (01) : 34 - 39
  • [5] Erythropoiesis-stimulating agents for preventing acute kidney injury
    Nishiwaki, H.
    Abe, Y.
    Suzuki, T.
    Hasegawa, T.
    Levack, W. M. M.
    Noma, H.
    Ota, E.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2024, (09):
  • [6] Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease
    Palmer, Suetonia C.
    Navaneethan, Sankar D.
    Craig, Jonathan C.
    Johnson, David W.
    Tonelli, Marcello
    GargMd, Amit X.
    Pellegrini, Fabio
    Ravani, Pietro
    Jardine, Meg
    Perkovic, Vlado
    Graziano, Giusi
    McGee, Richard
    Nicolucci, Antonio
    Tognoni, Gianni
    Strippoli, Giovanni F. M.
    ANNALS OF INTERNAL MEDICINE, 2010, 153 (01) : 23 - W23
  • [7] Modulation of Platelet Activation in Chronic Kidney Disease Patients on Erythropoiesis-Stimulating Agents
    Farag, Youssef M. K.
    Keithy-Reddy, Sai Ram
    Mittal, Bharati V.
    Bansal, Vinod
    Fareed, Jaweed
    Singh, Ajay K.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2012, 18 (05) : 453 - 461
  • [8] Responsiveness to erythropoiesis-stimulating agents and renal survival in patients with chronic kidney disease
    Kuwahara, Michio
    Mandai, Shintaro
    Kasagi, Yuri
    Kusaka, Keita
    Tanaka, Tomomi
    Shikuma, Satomi
    Akita, Wataru
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2015, 19 (04) : 598 - 605
  • [9] Responsiveness to Erythropoiesis-Stimulating Agents in Chronic Kidney Disease: Does Geography Matter?
    Luca De Nicola
    Francesco Locatelli
    Giuseppe Conte
    Roberto Minutolo
    Drugs, 2014, 74 : 159 - 168
  • [10] Responsiveness to erythropoiesis-stimulating agents and renal survival in patients with chronic kidney disease
    Michio Kuwahara
    Shintaro Mandai
    Yuri Kasagi
    Keita Kusaka
    Tomomi Tanaka
    Satomi Shikuma
    Wataru Akita
    Clinical and Experimental Nephrology, 2015, 19 : 598 - 605